Funded Tech Companies
NeoChord
Operating out of St. Louis Park, NeoChord has funding from Deerfield Capital, U.S. Venture Partners and Strategic Healthcare Investment Partners.
Company Overview
Company Name
NeoChord
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
5402 Parkdale Dr. 160
St. Louis Park, MN 55416
USA
St. Louis Park, MN 55416
USA
Phone
Website
Email Address
Company Background Information
Overview
NeoChord is a venture backed medical device company, is investigating minimally invasive technology intended to transform the treatment of degenerative mitral regurgitation.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/25/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Chung
Chief Financial Officer
Ronald Nelson
Chief Medical Officer
Ranny Chitwood
VP - Operations
Annette Doxon
VP - R & D
Daryl Edmiston
VP - Sales
Alex Jonkers
Company Investors
- Deerfield Capital (Avi Kometz)
- U.S. Venture Partners (Casey Tansey)
- Strategic Healthcare Investment Partners (Mudit Jain)
- Baird Capital (Nicole Walker)
- Hopen Life Science Ventures (Michael Fulton)
- CHV Capital (Kyle Salyers)
- Heron Capital (Gregory Maurer)
- TGAP Ventures (Jack Ahrens)
- Square 1 Bank
- Twilight Venture Partners (James Baumgardt)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs